Abaloparatide Not Yet Recruiting Phase 4 Trials for Femoral Fractures Treatment

IndicationsStatusPurposePhase
Not Yet RecruitingTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT04626141Supracondylar Distal Femur Fractures and Abaloparatide